Real-World Clinical Outcomes of Sulbactam-Durlobactam Against Carbapenem-Resistant Acinetobacter baumannii with Diverse β-Lactamase Profiles: A Multicenter Study in China

Chao Liu, Ying Chen, Lu Wang, Junwei Wang, Dong Xu, Zhongju Chen, Chengren Shu, Yan He

Open source

DOI
10.2147/idr.s614543
Published
2026-07
Container
Infection and Drug Resistance
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/idr.s614543,
  title = {Real-World Clinical Outcomes of Sulbactam-Durlobactam Against Carbapenem-Resistant Acinetobacter baumannii with Diverse β-Lactamase Profiles: A Multicenter Study in China},
  author = {Chao Liu and Ying Chen and Lu Wang and Junwei Wang and Dong Xu and Zhongju Chen and Chengren Shu and Yan He},
  year = {2026},
  journal = {Infection and Drug Resistance},
  doi = {10.2147/idr.s614543},
  url = {https://doi.org/10.2147/idr.s614543}
}

RIS

TY  - JOUR
TI  - Real-World Clinical Outcomes of Sulbactam-Durlobactam Against Carbapenem-Resistant Acinetobacter baumannii with Diverse β-Lactamase Profiles: A Multicenter Study in China
AU  - Chao Liu
AU  - Ying Chen
AU  - Lu Wang
AU  - Junwei Wang
AU  - Dong Xu
AU  - Zhongju Chen
AU  - Chengren Shu
AU  - Yan He
PY  - 2026
JO  - Infection and Drug Resistance
DO  - 10.2147/idr.s614543
UR  - https://doi.org/10.2147/idr.s614543
ER  - 

APA

Liu, C., Chen, Y., Wang, L., Wang, J., Xu, D., Chen, Z., Shu, C., & He, Y. (2026). Real-World Clinical Outcomes of Sulbactam-Durlobactam Against Carbapenem-Resistant Acinetobacter baumannii with Diverse β-Lactamase Profiles: A Multicenter Study in China. Infection and Drug Resistance. https://doi.org/10.2147/idr.s614543

Source records